{"title":"Pulsed Low-dose-rate Radiotherapy Remodels the Tumor Immune Microenvironment and is Associated With Crosstalk Between SPP1⁺ tumor-associated macrophages and GZMK⁺ CD8⁺ T cells.","authors":"Zihan Zhou, Yafang Hong, Jianhang You, Kaiqian Que, Yiming Lan, Yineng Lin, Junying Peng, Zhenyu Lin, Lanshan Li, Lu Han, Benhua Xu","doi":"10.1007/s10565-026-10324-7","DOIUrl":"10.1007/s10565-026-10324-7","url":null,"abstract":"<p><p>Pulsed low-dose-rate radiotherapy (PLDR) is a promising reirradiation strategy for refractory solid tumors because of its potential to reduce normal tissue toxicity; however, its immunomodulatory mechanisms remain poorly understood. In this study, we retrospectively analyzed clinical outcomes and treatment-related adverse events in 16 patients with refractory solid tumors treated with PLDR. Using MC38 tumor-bearing mice, we compared PLDR and conventional radiotherapy (cRT) under biologically equivalent dose conditions and performed single-cell RNA sequencing to characterize treatment-associated remodeling of the tumor immune microenvironment (TIM). Multiplex immunofluorescence staining and spatial analysis were further conducted in an independent cohort of 114 patients with rectal cancer to evaluate the clinical relevance of identified immune features. PLDR achieved comparable local tumor control to cRT while reducing treatment-related toxicity and improving overall survival (OS) in mouse models. In the combination-treatment setting, single-cell analyses showed that PLDR + immunotherapy with an anti-PD-1 antibody combined with the targeted agent anlotinib (ITT), compared with cRT + ITT, was associated with enrichment of Gzmk⁺ CD8⁺ T cells, reduced Spp1⁺ tumor-associated macrophages (TAMs) abundance, and altered cell-cell communication between these populations. In our independent rectal cancer cohort, the spatial distance between SPP1⁺ TAMs and GZMK⁺ CD8⁺ T cells was independently associated with OS. These findings suggest that the interaction between SPP1⁺ TAMs and GZMK⁺ CD8⁺ T cells may be closely associated with PLDR-related TIM remodeling and may also serve as a potential prognostic biomarker in rectal cancer.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"42 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13736382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"LncRNA TRHDE-AS1 functions as a tumor suppressor via the miR-22-5p/DLG3 axis to regulate malignant phenotypes and predict prognosis in glioma.","authors":"Qiufeng Dong, Junli Huo, Zhifeng Yan, Juan Li, Xiaoyan Chen, Liwen Li, Haining Zhen","doi":"10.1007/s10565-026-10266-0","DOIUrl":"https://doi.org/10.1007/s10565-026-10266-0","url":null,"abstract":"<p><strong>Background: </strong>Long noncoding RNAs (lncRNAs) represent a significant avenue for investigating tumor molecular mechanisms and identifying potential therapeutic targets.</p><p><strong>Objective: </strong>It was aimed to explore the expression and prognostic significance of lncRNA TRHDE-AS1 in glioma, and clarify its ceRNA-mediated regulation of miR-22-5p/DLG3 axis in promoting glioma progression in vitro.</p><p><strong>Materials and methods: </strong>Using the TCGA database and clinical glioma tissue samples (n = 150), qRT-PCR was employed to detect the expression of TRHDE-AS1. Its prognostic value was assessed through Kaplan-Meier analysis and Cox regression analysis. The targeting interaction between TRHDE-AS1, miR-22-5p and DLG3 was confirmed by luciferase reporter assay and RNA Immunoprecipitation (RIP) experiments. Using CCK-8 and Transwell assays, the impact of TRHDE-AS1 on glioma cells' malignant phenotypes was evaluated. To assess the influence on epithelial-mesenchymal transition (EMT), the protein levels of N-cadherin, Snail, and MMP-2 were measured via Western blot.</p><p><strong>Results: </strong>Low expression of TRHDE-AS1 in glioma tissues correlated with patients' malignant features, consistent with findings from the TCGA database. It was independently related to reduced overall survival. Upon TRHDE-AS1 upregulation, miR-22-5p levels significantly decreased while downstream target DLG3 expression increased in both U251 and LN229 cells. The proliferation, invasive metastatic ability and EMT of both cells were significantly reduced, which was offset by miR-22-5p overexpression. TRHDE-AS1/miR-22-5p mediated cellular phenotype alterations were restored by DLG3 again in both U251 and LN229 cells.</p><p><strong>Conclusion: </strong>Downregulation of TRHDE-AS1 was closely related to glioma patients' poor prognosis. It may regulate miR-22-5p/DLG3 axis through the ceRNA mechanism to promote the malignant activity of glioma cells.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"42 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759650/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Analyzing per- and polyfluoroalkyl substances (PFAS) in triple-negative breast cancer (TNBC): an integrative transcriptomic and computational study.","authors":"Ningxin Qu, Pisong Li, Xiaoyu Zhu, Hui Qu, Zhongbin Han, Zechang Xin, Hongshen Chen","doi":"10.1007/s10565-026-10250-8","DOIUrl":"10.1007/s10565-026-10250-8","url":null,"abstract":"<p><strong>Background: </strong>Per- and polyfluoroalkyl substances (PFAS), including perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), are persistent environmental contaminants. Epidemiological studies have associated PFAS exposure with several cancers, but TNBC-specific molecular evidence remains limited.</p><p><strong>Methods: </strong>We integrated computational target prediction, network analysis, bulk transcriptomic and microarray cohorts, single-cell RNA sequencing, spatial transcriptomics, prognostic modeling, molecular docking, molecular dynamics simulation, and expression assessment in 15 paired TNBC and adjacent tissues. The public patient cohorts and tissue specimens did not contain measured PFAS exposure, so all PFAS-related interpretations were prespecified as associative and hypothesis-generating. Results The intersection of 654 predicted PFAS targets, 3,944 TNBC-associated genes, and 27,529 TNBC differentially expressed genes yielded 197 candidates. A hypergeometric test indicated that this overlap exceeded chance expectation (observed/expected = 3.22, P = 3.65 × 10 - 52), although the permissive DEG set and heterogeneous disease-gene sources remain important limitations. Six candidate genes (CDK9, PF4, VEGFC, FABP7, NR2F6, and PLAU) formed the prognostic signature. The 2-year training-set AUC of 0.999 was interpreted as probable optimism rather than clinical-level performance. RT-qPCR showed significant differences for CDK9, PF4, VEGFC, FABP7, and NR2F6, whereas PLAU was directionally increased but not significant. Docking and simulation supported computational compatibility for selected protein-PFAS complexes but did not demonstrate cellular target engagement.</p><p><strong>Conclusions: </strong>The findings define a TNBC gene signature that overlaps with predicted PFAS targets and provide a testable computational hypothesis. Causal inference requires PFAS-stratified patient cohorts, direct exposure transcriptomics, dose-response experiments, and independent prospective validation.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"42 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Guoshuo Chen, Yingwen Zhu, Guangfeng Duan, Tao Zhang, Ruyi Lu, Man Lu, Jike Du
{"title":"The mechanism of METTL6/DALRD3 regulating cell cycle-mediated chemoresistance in hepatocellular carcinoma.","authors":"Guoshuo Chen, Yingwen Zhu, Guangfeng Duan, Tao Zhang, Ruyi Lu, Man Lu, Jike Du","doi":"10.1007/s10565-026-10243-7","DOIUrl":"10.1007/s10565-026-10243-7","url":null,"abstract":"<p><strong>Objective: </strong>Chemoresistance worsens the prognosis of hepatocellular carcinoma (HCC). This study focuses on how methyltransferase-like protein 6 (METTL6)/DALR anticodon binding domain containing 3 (DALRD3) regulates cell cycle progression and impacts HCC chemoresistance.</p><p><strong>Methods: </strong>HCC cell lines with relatively low or high METTL6 expression were intervened with cisplatin (DDP) to construct DDP-resistant cell models, and later transfected with overexpression (oe)-METTL6 plasmid, oe-DALRD3 plasmid, small interfering RNA (si)-METTL6, and/or si-DALRD3. A battery of cellular biological functional experiments and DDP drug sensitivity tests were performed to characterize the modulatory effects of METTL6 or DALRD3 on HCC chemoresistance. The interaction between METTL6 and DALRD3 was validated using coimmunoprecipitation. 3-methylcytosine (m<sup>3</sup>C) modification and expression were further detected using dot blot and Northern blot assays. A subcutaneous xenograft mouse model was established with METTL6- or DALRD3-deficient HCC cells, which were exposed to DDP for experimental validation of in vitro findings.</p><p><strong>Results: </strong>METTL6 and DALRD3 were upregulated in DDP-resistant HCC cells, and their upregulation in HCC tissues correlated with poor prognosis. Re-expression of METTL6 or DALRD3 led to strengthened cell proliferation, aggravated cell cycle progression, and augmented DDP chemoresistance. The validated METTL6-DALRD3 interaction increased m<sup>3</sup>C modification. Northern blot further validated serine transfer RNA-m<sup>3</sup>C at position 32 (tRNA<sup>Ser</sup>-m<sup>3</sup>C32) modification mediated by the METTL6-DALRD3 complex. Rescue experiments unveiled that DALRD3 overexpression reversed METTL6 knockdown-mediated HCC phenotypes. Either METTL6 or DALRD3 knockdown potentiated DDP chemosensitivity in HCC xenograft mice.</p><p><strong>Conclusions: </strong>METTL6/DALRD3 mediated tRNA<sup>Ser</sup>-m<sup>3</sup>C32 modification may participate in DDP resistance in HCC cells by regulating cell cycle progression.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"42 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751759/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yan Wang, Lanbo Wang, Aodi Li, Lei Zhao, Lidan Liu, Xiangli Liu
{"title":"Fibroblast-driven matrix remodeling shapes immune exclusion in lung cancer.","authors":"Yan Wang, Lanbo Wang, Aodi Li, Lei Zhao, Lidan Liu, Xiangli Liu","doi":"10.1007/s10565-026-10245-5","DOIUrl":"10.1007/s10565-026-10245-5","url":null,"abstract":"<p><p>The lung tumor microenvironment (TME) is shaped by reciprocal interactions among cancer-associated fibroblasts (CAFs), extracellular matrix (ECM), immune cells, endothelial cells, and tumor cells. Available evidence supports an integrated sequence in which tumor-derived factors, chronic tissue injury, inflammatory cytokines, and mechanical stress generate context-dependent CAF states. Matrix-producing CAFs subsequently deposit, align, and crosslink fibrillar collagen, whereas inflammatory and antigen-presenting CAF programs regulate chemokine gradients, myeloid-cell recruitment, and local T-cell responses. These structural and biochemical changes converge to reduce vascular perfusion, restrict lymphocyte movement from stromal regions into malignant-cell nests, and promote functional immune suppression, thereby contributing to resistance to immune checkpoint blockade. The supporting evidence has been obtained from complementary systems, including single-cell and spatial profiling of human lung tumors, live imaging of human lung tumor slices, primary fibroblast-tumor cell co-cultures, three-dimensional collagen or organoid models, orthotopic xenografts, and immune-competent murine lung cancer models. Because each platform captures only part of the CAF-ECM-immune axis, conclusions should distinguish clinical association from causal evidence and specify the biological system in which a mechanism was demonstrated. Stromal signatures, collagen architecture, and spatial immune-exclusion patterns may complement tumor-intrinsic biomarkers, but their utility for treatment selection remains investigational and requires analytical standardization and prospective validation. Therapeutic development may therefore prioritize phenotype-selective CAF reprogramming and functional matrix normalization over indiscriminate fibroblast depletion, while recognizing that no single stromal feature is currently sufficient to direct clinical management. Importantly, CAF activation and ECM deposition are not uniformly tumor promoting: depending on disease stage, fibroblast state, collagen topology, and immune context, selected stromal programs may physically contain early lesions or support local immune organization. This context dependence further supports cautious, biomarker-informed evaluation of stromal interventions rather than generalized depletion. Throughout this review, spatial co-occurrence and neighborhood enrichment are treated as hypothesis-generating associations unless they are supported by temporally resolved, cell-specific perturbation and rescue experiments.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"42 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13739994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fanyun Kong, Yuxin Wang, Lu Yang, Rong Jiang, Yujie Zhong, Huanyang Zhang, Ensi Bao, Xuanke Liu, Xiangye Liu, Xia Wang, Xiucheng Pan, Suping Qin, Kuiyang Zheng, Chen Li, Renxian Tang, Hongjuan You
{"title":"Hepatitis B virus X protein stabilizes TPM1 to epigenetically inhibit ALDH2 and drive liver cancer progression.","authors":"Fanyun Kong, Yuxin Wang, Lu Yang, Rong Jiang, Yujie Zhong, Huanyang Zhang, Ensi Bao, Xuanke Liu, Xiangye Liu, Xia Wang, Xiucheng Pan, Suping Qin, Kuiyang Zheng, Chen Li, Renxian Tang, Hongjuan You","doi":"10.1007/s10565-026-10241-9","DOIUrl":"10.1007/s10565-026-10241-9","url":null,"abstract":"<p><p>As a major viral oncogenic factor, the hepatitis B virus (HBV) X protein (HBx) critically contributes to the malignant progression of liver cancer (LC). Although cytoskeletal proteins are implicated in HBx-mediated tumorigenesis, their specific functions and underlying mechanisms in HBx-associated LC remain largely underexplored. Here, we identified that tropomyosin 1 (TPM1), an actin-binding cytoskeletal protein, is significantly overexpressed in HBx-positive LC cells and HBV-associated tumor tissues. Both in vitro and in vivo experiments demonstrated that TPM1 contributes to HBx-induced growth and migration of LC cells. Furthermore, HBx can stabilize TPM1 by disrupting its interaction with SYVN1, an E3 ubiquitin ligase. Additionally, aldehyde dehydrogenase 2 (ALDH2) was identified as a key downstream effector of TPM1. TPM1 markedly downregulates ALDH2 expression, leading to cholesterol accumulation. Specifically, TPM1 binds to histone deacetylase 2 (HDAC2), an epigenetic coregulator, and represses ALDH2 transcription by reducing histone acetylation at the ALDH2 promoter region. Interestingly, HBx enhances the interaction of TPM1with HDAC2, resulting in greater downregulation of ALDH2. Through high-throughput virtual screening and experimental validation, dihydroergotamine mesylate was further identified as a specific TPM1 inhibitor. This compound exerted potent antitumor effects by counteracting HBx-induced cholesterol accumulation and oncogenic phenotypes in LC cells. Collectively, these results delineate a mechanism by which the cytoskeletal protein TPM1 facilitates HBx-induced hepatocarcinogenesis and highlight TPM1 as a promising therapeutic target for HBV-positive LC. suppressing histone acetylation. DHE, a newly identified inhibitor of TPM1, restrains HBx-mediated LC cell biological behaviors.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"42 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Integrating single-cell transcriptomics, molecular dynamics, and functional assays to characterize the STING-P4HA1 immunometabolic axis in Parkinson's disease.","authors":"Yinhui Huang, Mingmei Li, Meizhi Wang, Zhenjie Chen, Wanli Huang, Binbin Yu, Meifeng Wang, Yafang Chen, Mimi Li","doi":"10.1007/s10565-026-10238-4","DOIUrl":"https://doi.org/10.1007/s10565-026-10238-4","url":null,"abstract":"<p><strong>Background: </strong>Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) stabilizes the collagen triple helix and is increasingly implicated in non-canonical metabolic processes, though the structural basis of these roles remains poorly understood.</p><p><strong>Methods: </strong>We combined single-cell RNA sequencing (scRNA-seq) with high-dimensional weighted gene co-expression network analysis (hdWGCNA) to identify P4HA1 in microglia with high STING activity. Functional validation was performed in MPTP mice and MPP⁺-stimulated BV2 microglia using AAV-shRNA-mediated knockdown, Seahorse metabolic flux analysis, and assays for oxidative stress and polarization. Druggability was evaluated by virtual screening of an FDA-approved drug library, and the top complex underwent 100 ns molecular dynamics (MD) simulations assessing RMSD, Rg, SASA, and free energy landscape (FEL).</p><p><strong>Results: </strong>P4HA1 was upregulated in Parkinson's disease (PD) models, promoting a glycolytic shift-evidenced by increased ECAR and suppressed mitochondrial OCR-that drove ROS production, mitochondrial depolarization, and M1 microglial polarization. P4HA1 knockdown attenuated dopaminergic neuron loss and improved motor and cognitive deficits in MPTP mice. Virtual screening identified Exatecan as a high-affinity P4HA1 inhibitor (-12.2 kcal/mol). MD simulations confirmed complex stability and revealed anisotropic compaction toward a global free energy minimum.</p><p><strong>Conclusion: </strong>Our findings establish a structural and dynamic basis for the non-canonical immunometabolic function of P4HA1, supporting its potential as a therapeutic target in PD.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"42 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zhengyu Li, Bing Bao, Xinyu Yang, Jun Min, Zhiping Wu, Weiping Chen, Min Yin
{"title":"PAR4 exacerbates intracerebral hemorrhage by driving m6A-dependent microglial AIM2 release and neuronal PANoptosis.","authors":"Zhengyu Li, Bing Bao, Xinyu Yang, Jun Min, Zhiping Wu, Weiping Chen, Min Yin","doi":"10.1007/s10565-026-10237-5","DOIUrl":"10.1007/s10565-026-10237-5","url":null,"abstract":"<p><strong>Background: </strong>Intracerebral hemorrhage (ICH) is a neurological disorder with high morbidity and mortality. PAR4 has been implicated in ICH and neuroinflammation.</p><p><strong>Methods: </strong>The rat model of intracerebral hemorrhage (ICH) was established by injecting collagenase into the brain. TTC staining, H&E staining, and immunofluorescence were used to evaluate the brain tissue. In vitro, rat primary microglia (RPMCs) were isolated and the rat microglial cell line HAPI and the hippocampal neuronal cell line H19-7 were cultured. RNA-seq analysis, Western blot, co-immunoprecipitation, cell immunofluorescence, RIP assay, m<sup>6</sup>A Dot Blot Analysis were performed to investigate the role of PAR4 and its downstream signaling pathways.</p><p><strong>Results: </strong>In the ICH rat model, treatment with the PAR4 antagonist inhibited neuronal death and reversed the M1-dominant shift of microglia. PAR4 regulated m<sup>6</sup>A methylation in microglia via KIAA1429-mediated recruitment of methyltransferase complexes. PAR4AP increased JAK2 mRNA m<sup>6</sup>A modification, mRNA and protein levels, and enhanced STAT3 protein phosphorylation. It also increased the expression of inflammatory factors and inflammasome components, with a stronger effect on AIM2 expression. PAR4AP enhanced AIM2 expression in microglial cells through mechanisms dependent on the JAK2/STAT3 signaling pathway and m<sup>6</sup>A modification. PAR4AP-activated microglia induce neuronal PANoptosis via exosome-mediated transfer of AIM2, promoting Pyrin-ZBP1 complex formation. In a rat model of ICH, lentivirus-delivered shRNAs targeting KIAA1429, FMR1, and AIM2, as well as PAR4 inhibition, suppressed PANoptosis in neuronal cells.</p><p><strong>Conclusion: </strong>This study provides insights into the role of PAR4 in ICH and its downstream signaling pathways, suggesting potential therapeutic targets for ICH treatment.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"42 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13727903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}